The Aleo Network Foundation Announces Partnership with Fintech Unicorn Revolut
'Joining forces with Revolut reinforces our mission to embed privacy at the foundation of tomorrow's financial systems,' said Josh Hawkins, EVP of Strategy, Policy & Communications.
Revolut stands as Europe's most crypto-friendly fintech, offering a trusted platform for trading and storing digital assets. In parallel, the Aleo Network (Aleo) brings a critical layer to the blockchain ecosystem: powered by zero-knowledge cryptography, it provides a foundational infrastructure layer that other blockchains, stablecoins, and enterprises can integrate to ensure both privacy and compliance. With MiCA regulations now establishing clear, unified standards across Europe, a path for innovation, compliant blockchain growth, and private payments has emerged. Aleo's integration with Revolut can help shape the future of blockchain systems for developers and institutions building the next generation of digital asset technology.
'Joining forces with Revolut reinforces our mission to embed privacy at the foundation of tomorrow's financial systems,' said Josh Hawkins, EVP of Strategy, Policy & Communications. 'By treating privacy not as a barrier but as a catalyst for innovation and compliance, we're helping to ensure that blockchain continues to evolve as a tool for empowerment, and not surveillance. This listing brings us closer to a future where privacy is a core feature, not an afterthought, in the global financial stack.'
About The Aleo Network
The Aleo Network is building the infrastructure for the next generation of private, decentralized applications. Using zero-knowledge cryptography, Aleo enables scalable, off-chain execution with on-chain verification — delivering privacy without compromising programmability. Developers can build powerful, secure applications without exposing user data.
As the industry continues to push toward more secure and privacy-first solutions, Aleo remains committed to making privacy a native, accessible feature for all builders on the decentralized web. For more information about Aleo and to stay updated on its latest developments, visit www.aleo.org.
About Revolut Crypto
Revolut is Europe's leading fintech with over 60 million users globally. We bridge traditional finance with crypto, delivering a seamless and comprehensive Crypto offering to more than 12 million users across the UK and EEA.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 hours ago
- Business Wire
Sensorion Announces an Increase in Resources Allocated to the Liquidity Contract with Kepler Cheuvreux
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announces an increase in resources allocated to the liquidity contract entrusted to Kepler Cheuvreux. On 15 December 2017 Sensorion entered into a Liquidity Contract with Kepler Cheuvreux, modified by amendments dated 7 December 2018 and 15 July 2022 (the " Contract"). This Contract aims to promote the liquidity of the Shares of Sensorion on Euronext Paris. On 14 August 2025, in accordance with Article 4 of AMF Decision No. 2021-01 of 22 June 2021 renewing the establishment of liquidity contracts on equity securities as an accepted market practice, Sensorion increased the resources allocated to the liquidity contract by €60,000. Following this increase in resources, as of 14 August 2025, the following assets appear on the liquidity account: - 206,211 Sensorion Ordinary Shares - €66,965.21 About Sensorion Sensorion is a pioneering clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent hearing loss disorders, a significant global unmet medical need. Sensorion has built a unique R&D technology platform to expand its understanding of the pathophysiology and etiology of inner ear related diseases, enabling it to select the best targets and mechanisms of action for drug candidates. It has two gene therapy programs aimed at correcting hereditary monogenic forms of deafness, developed in the framework of its broad strategic collaboration focused on the genetics of hearing with the Institut Pasteur. SENS-501 (OTOF-GT) currently being developed in a Phase 1/2 clinical trial, targets deafness caused by mutations of the gene encoding for otoferlin and GJB2-GT targets hearing loss related to mutations in GJB2 gene to potentially address important hearing loss segments in adults and children. The Company is also working on the identification of biomarkers to improve diagnosis of these underserved illnesses. Sensorion's portfolio also comprises programs of a clinical-stage small molecule, SENS-401 (Arazasetron), for the treatment and prevention of hearing loss disorders. Sensorion's small molecule progresses in a Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) for the preservation of residual hearing. Sensorion, with partner Cochlear Limited, completed in 2024 a Phase 2a study of SENS-401 for the residual hearing preservation in patients scheduled for cochlear implantation. A Phase 2 study of SENS-401 was also completed in Sudden Sensorineural Hearing Loss (SSNHL) in January 2022. Disclaimer This press release contains certain forward-looking statements concerning Sensorion and its business. Such forward looking statements are based on assumptions that Sensorion considers to be reasonable. However, there can be no assurance that such forward-looking statements will be verified, which statements are subject to numerous risks, including the risks set forth in the 2024 full year report published on March 14, 2025, and available on our website and to the development of economic conditions, financial markets and the markets in which Sensorion operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Sensorion or not currently considered material by Sensorion. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Sensorion to be materially different from such forward-looking statements. This press release and the information that it contains do not constitute an offer to sell or subscribe for, or a solicitation of an offer to purchase or subscribe for, Sensorion shares in any country. The communication of this press release in certain countries may constitute a violation of local laws and regulations. Any recipient of this press release must inform oneself of any such local restrictions and comply therewith.
Business Wire
6 hours ago
- Business Wire
ESS Schedules Second Quarter 2025 Financial Results Conference Call
WILSONVILLE, Ore.--(BUSINESS WIRE)--ESS Tech, Inc. (ESS) (NYSE: GWH), a leading manufacturer of iron flow long-duration energy storage (LDES) systems for commercial- and utility-scale applications, today announced that it will hold a conference call on Thursday, August 14, 2025 at 5:00 p.m. EDT to discuss financial results for its second quarter 2025 ended June 30, 2025. The news release announcing the second quarter 2025 financial results will be disseminated on August 14, 2025 after the market closes. Interested parties may join the conference call beginning at 5:00 p.m. EDT on Thursday, August 14, 2025 via telephone by calling (833) 470-1428 in the U.S., or for international callers, by calling +1 (404) 975-4839 and entering conference ID 271308. A telephone replay will be available until August 21, 2025, by dialing (866) 813-9403 in the U.S., or for international callers, +1 (929) 458-6194 with conference ID 482125. A live webcast of the conference call will be available on ESS' Investor Relations website at A replay of the call will be available via the web at About ESS Tech, Inc. At ESS (NYSE: GWH), we deliver safe, sustainable, long-duration energy storage to ensure energy abundance and security. As energy demand continues to grow, our solutions provide essential reliability and resilience to people, communities, and businesses in the United States and throughout the world. Our technology uses earth-abundant iron, salt and water to deliver environmentally safe solutions capable of providing 10+ hours of flexible energy capacity for commercial and utility-scale energy storage applications. Established in 2011, ESS enables project developers, independent power producers, utilities and other large energy users to deploy reliable, sustainable long-duration energy storage solutions. For more information, visit
Business Wire
7 hours ago
- Business Wire
AM Best to Speak in a Session at the 2025 CAS China Insurance Summit
HONG KONG--(BUSINESS WIRE)-- AM Best will participate in a session during the Casualty Actuarial Society's fourth annual China Insurance Summit, taking place on Aug. 22, 2025, at the Mingyu Chengdu Dongda Hotel in Chengdu, China. Christie Lee, senior director, head of analytics, will speak at 2:30 p.m. CST in a session titled, 'Reinsurance Market Development Trends.' Additional AM Best attendees will include Judy Li, market development analyst, and Lucie Huang, senior financial analyst. Participants will be able to attend in-person or virtually. The event will be conducted in Mandarin, with limited sessions in English. This summit will feature an action-packed schedule with a broad range of topics. To learn more about the summit, visit the event website. To schedule a meeting, please contact Judy Li, or James Chan, Copyright © 2025 by A.M. Best Company, Inc. and/or its affiliates. ALL RIGHTS RESERVED.
